Joseph Gimbel

2.1k total citations
37 papers, 1.4k citations indexed

About

Joseph Gimbel is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Physiology. According to data from OpenAlex, Joseph Gimbel has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Anesthesiology and Pain Medicine and 14 papers in Physiology. Recurrent topics in Joseph Gimbel's work include Pain Management and Opioid Use (15 papers), Pain Mechanisms and Treatments (14 papers) and Opioid Use Disorder Treatment (13 papers). Joseph Gimbel is often cited by papers focused on Pain Management and Opioid Use (15 papers), Pain Mechanisms and Treatments (14 papers) and Opioid Use Disorder Treatment (13 papers). Joseph Gimbel collaborates with scholars based in United States, Israel and Australia. Joseph Gimbel's co-authors include P. Richards, Russell K. Portenoy, M. Hale, Kenneth M. Verburg, Chris Dvergsten, Christine R. West, D.S. Keller, Harry Ahdieh, William W. Zhao and Andrew Brugger and has published in prestigious journals such as Neurology, Pain and Spine.

In The Last Decade

Joseph Gimbel

36 papers receiving 1.4k citations

Peers

Joseph Gimbel

PHYSI

PHARM

APM

SURGE

PHEOH

Amitabh Gulati United States

C. Bonezzi Italy

Hue Jung Park South Korea

Edoardo Arcuri Italy

George Groeneweg Netherlands

Anne‐Priscille Trouvin France

Line Jacques Canada

L. LaMoreaux United States

Jan Dobrogowski Poland

Jonathan M. Hagedorn United States

Amitabh Gulati United States

Joseph Gimbel

438 ×0.7

PHYSI

261 ×0.5

PHARM

660 ×1.3

APM

556 ×1.3

SURGE

198 ×0.8

PHEOH

Citations per year, relative to Joseph Gimbel Joseph Gimbel (= 1×) peers Amitabh Gulati

Countries citing papers authored by Joseph Gimbel

Since Specialization

Citations

This map shows the geographic impact of Joseph Gimbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Gimbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Gimbel more than expected).

Fields of papers citing papers by Joseph Gimbel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Gimbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Gimbel. The network helps show where Joseph Gimbel may publish in the future.

Co-authorship network of co-authors of Joseph Gimbel

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Gimbel. A scholar is included among the top collaborators of Joseph Gimbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Gimbel. Joseph Gimbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Viscusi, Eugene R., Oscar A. de León-Casasola, Adam Jacobs, et al.. (2022). Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial. Pain Practice. 23(1). 8–22. 18 indexed citations

Scotti, Celeste, Joseph Gimbel, Didier Laurent, et al.. (2021). First-in-human trial results of LNA043, a novel cartilage regenerative treatment for osteoarthritis. Osteoarthritis and Cartilage. 29. S214–S214. 1 indexed citations

Dakin, Paula, Alan Kivitz, Joseph Gimbel, et al.. (2020). Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial. Annals of the Rheumatic Diseases. 80(4). 509–517. 26 indexed citations

Viscusi, Eugene R., et al.. (2019). HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study. Regional Anesthesia & Pain Medicine. 44(7). 700–706. 39 indexed citations

Singla, Neil, M. Hale, Jeffrey C. Davis, et al.. (2014). IV Acetaminophen. American Journal of Therapeutics. 22(1). 2–10. 33 indexed citations

Chelly, Jacques E., David R. Lionberger, Joseph Gimbel, et al.. (2014). Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models. Journal of Pain Research. 8. 9–9. 41 indexed citations

Gimbel, Joseph, Alan Kivitz, Candace Bramson, et al.. (2014). Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain. Pain. 155(9). 1793–1801. 44 indexed citations

Ekman, Evan F., Joseph Gimbel, Alfonso E. Bello, et al.. (2014). Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen. The Journal of Rheumatology. 41(11). 2249–2259. 71 indexed citations

Kivitz, Alan, Joseph Gimbel, Candace Bramson, et al.. (2013). Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain. 154(7). 1009–1021. 113 indexed citations

10.

Richards, P., et al.. (2013). Comparison of the Efficacy and Safety of Dual-Opioid Treatment With Morphine Plus Oxycodone Versus Oxycodone/Acetaminophen for Moderate to Severe Acute Pain After Total Knee Arthroplasty. Clinical Therapeutics. 35(4). 498–511. 15 indexed citations

11.

Gimbel, Joseph, et al.. (2011). Effectiveness and Safety of Diclofenac Epolamine Topical Patch 1.3% for the Treatment of Acute Pain Due to Back Strain: An Open-Label, Uncontrolled Study. The Physician and Sportsmedicine. 39(1). 11–18. 5 indexed citations

12.

Viscusi, Eugene R., Joseph Gimbel, Andreas M. Halder, et al.. (2008). A Multiple-Day Regimen of Parecoxib Sodium 20 mg Twice Daily Provides Pain Relief After Total Hip Arthroplasty. Anesthesia & Analgesia. 107(2). 652–660. 19 indexed citations

13.

Gimbel, Joseph. (2008). Oxymorphone: A mature molecule with new life. Drugs of today. 44(10). 767–767. 2 indexed citations

14.

Aqua, Keith, Joseph Gimbel, Neil Singla, et al.. (2007). Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clinical Therapeutics. 29(6). 1000–1012. 24 indexed citations

15.

Gimbel, Joseph, Richard T. Linn, M. Hale, & Bruce Nicholson. (2005). Lidocaine Patch Treatment in Patients with Low Back Pain: Results of an Open-Label, Nonrandomized Pilot Study. American Journal of Therapeutics. 12(4). 311–319. 80 indexed citations

16.

Gimbel, Joseph, et al.. (2005). Efficacy and Safety of Oxymorphone Immediate Release for the Treatment of Mild to Moderate Pain After Ambulatory Orthopedic Surgery: Results of a Randomized, Double-Blind, Placebo-Controlled Trial. Archives of Physical Medicine and Rehabilitation. 86(12). 2284–2289. 13 indexed citations

17.

Hale, M., Chris Dvergsten, & Joseph Gimbel. (2004). Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study. Journal of Pain. 6(1). 21–28. 131 indexed citations

18.

Gimbel, Joseph & Harry Ahdieh. (2004). The Efficacy and Safety of Oral Immediate-Release Oxymorphone for Postsurgical Pain. Anesthesia & Analgesia. 99(5). 1472–1477. 39 indexed citations

19.

Katz, Nathaniel P., William D. Ju, David Krupa, et al.. (2003). Efficacy and Safety of Rofecoxib in Patients with Chronic Low Back Pain. Spine. 28(9). 851–858. 45 indexed citations

20.

Katz, Nathaniel P., William Ju, David Krupa, et al.. (2003). . Spine. 28(9). 851–858. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact